ArticleJournal of medicinal chemistry2026
Selective Nanobody-Derived Minibodies Targeting Galectin-1 and -7 Reveal Non-Redundant Glyco-Immune Functions and Therapeutic Potential in Triple-Negative Breast Cancer.
Rita Nehmé et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.